Onderneming Celltrion Healthcare Co., Ltd.
Aandelen
A091990
KR7091990002
Farmaceutische producten
Vakgebied
Aantal werknemers: 120
Verkoop per activiteit
KRW in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
98,9
%
| 1 783 637 | 98,6 % | 1 950 503 | 98,9 % | +9,36% |
Other
1,0
%
| 17 794 | 1,0 % | 19 520 | 1,0 % | +9,70% |
Service Provision
0,1
%
| 7 008 | 0,4 % | 2 165 | 0,1 % | -69,11% |
Verkoop per regio
KRW in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
North America
39,8
%
| 726 201 | 40,2 % | 785 912 | 39,8 % | +8,22% |
Europe
35,8
%
| 782 074 | 43,3 % | 705 571 | 35,8 % | -9,78% |
Asia
14,0
%
| 200 024 | 11,1 % | 275 578 | 14,0 % | +37,77% |
South America and Others
10,0
%
| 94 551 | 5,2 % | 197 686 | 10,0 % | +109,08% |
South Korea
0,4
%
| 1 636 | 0,1 % | 7 441 | 0,4 % | +354,83% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 62 | - |
Jung Kim
CMP | Compliance Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Han
BRD | Director/Board Member | 68 | 29-03-16 |
Jung-Jin Seo
CHM | Chairman | 66 | - |
Wu-Sung Ki
CEO | Chief Executive Officer | 62 | - |
Eung-Yeol Choe
BRD | Director/Board Member | 66 | 29-03-18 |
Un-Gab Jeong
BRD | Director/Board Member | 57 | 29-03-18 |
Hyeon-Ju Ra
BRD | Director/Board Member | 59 | 29-05-18 |
Han-Gi Lee
BRD | Director/Board Member | 47 | 01-01-11 |
Joong-Jae Lee
BRD | Director/Board Member | 61 | - |
Jun-Seok Seo
CHM | Chairman | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 164 464 724 | 97 611 660 ( 59,35 %) | 5 141 351 ( 3,126 %) | 59,35 % |
Bedrijfsgegevens
Celltrion Healthcare Co., Ltd.
19, Academy-ro 51beon-gil Yeonsu-gu
22014, Inchon
+82 3 2850 6400
http://www.celltrionhealthcare.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,35 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |